HLA-C and posterior cortical atrophy: Secondly, we did not address the potential molecular mechanism underlying the alteration of the low expression of MHC in CDK12-mut PCa, as shown in our patient 17, including epigenetic alterations, miRNA activity, and potential influence of adjuvant therapies on MHC expression and immune TME dynamics.